SFC Type 11 License for OTC Derivative Clearing Services: Regulatory Framework Explained

On 2 January 2025, the Hong Kong Monetary Authority (HKMA) and the Securities and Futures Commission (SFC) published a joint consultation conclusion confirming that mandatory clearing of over-the-counter (OTC) derivative transactions through a central counterparty (CCP) will expand to cover new product classes from mid-2025. This regulatory shift, aligned with the Financial Stability Board’s post-2008 reform timetable, directly impacts any firm that books OTC derivative trades in Hong Kong. The SFC Type 11 license, introduced under the Securities and Futures Ordinance (Cap. 571) in 2020, is the sole regulatory gateway for providing OTC derivative clearing services. As the new clearing obligations take effect, the number of firms requiring this license is expected to rise sharply. The SFC reported in its 2023-24 Annual Report that only 14 licensed corporations held a Type 11 license as of 31 March 2024. That number will need to grow as the clearing mandate widens. This article explains the regulatory framework, the application process, and the ongoing compliance obligations for a Type 11 license.

The Regulatory Basis for Type 11 Licensing

The SFC Type 11 license authorises a corporation to provide “OTC derivative clearing services.” This is a defined activity under Part V of the Securities and Futures Ordinance (Cap. 571) and Schedule 5. The SFC introduced the license in 2020 to implement the G20 commitment to central clearing of standardised OTC derivatives.

Definition of the regulated activity. Section 114 of Cap. 571 requires any person carrying on a business in a regulated activity to be licensed by the SFC. Schedule 5 defines Type 11 as “dealing in OTC derivative products” and “providing OTC derivative clearing services.” The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the SFC Code) provides further guidance. Paragraph 19 of the SFC Code sets out specific conduct requirements for clearing members and clients. The key distinction is between acting as a clearing member (direct access to a CCP) and providing clearing services to clients (indirect access).

Who must be licensed. Any corporation that operates as a clearing member of a recognised CCP in Hong Kong, or that provides clearing services to clients in respect of OTC derivative transactions, must hold a Type 11 license. This includes banks, broker-dealers, and specialist clearing firms. The HKMA and SFC joint statement of 25 July 2022 confirmed that authorised institutions (banks) may also need a Type 11 license if they provide clearing services beyond their own proprietary positions. Exemptions exist for firms that only clear their own trades and do not hold client money or assets.

Relationship with other licenses. A Type 11 license is typically held alongside a Type 1 (dealing in securities) or Type 2 (dealing in futures contracts) license. The SFC’s Licensing Handbook (January 2024 edition) states that a Type 11 licensee must also be licensed for Type 1 or Type 2 if it deals in the underlying OTC derivative products. This is a common requirement for firms that execute trades and then clear them.

The Application Process and Key Requirements

Applying for a Type 11 license follows the standard SFC licensing process under Part V of Cap. 571, with specific additional requirements due to the nature of clearing activities.

Step 1: Determine the appropriate corporate structure. The SFC requires the applicant to be a Hong Kong-incorporated company with a physical office in Hong Kong. The SFC’s Guidelines on the Application for Licences (January 2023) specify that the applicant must have at least two responsible officers (ROs) who are ordinarily resident in Hong Kong. At least one RO must be a director of the company. For Type 11, the SFC expects ROs to have at least five years of relevant experience in OTC derivative clearing, settlement, or risk management.

Step 2: Prepare the application package. Form LC-1 (for the corporation) and Form LC-3 (for each individual RO) must be submitted. The SFC requires the following supporting documents:

• A business plan detailing the proposed clearing services, target clients, and revenue projections.
• A risk management policy covering credit risk, liquidity risk, and operational risk.
• A compliance manual addressing the SFC Code and the Code of Conduct for Clearing Members issued by the relevant CCP.
• Evidence of financial resources: the SFC’s Financial Resources Rules (Cap. 571N) require a licensed corporation to maintain liquid capital of at least HK$5 million for Type 11. However, the SFC may impose a higher requirement based on the volume of clearing activity. The SFC’s 2023-24 Annual Report noted that the median liquid capital held by Type 11 licensees was HK$50 million.

Step 3: Demonstrate clearing infrastructure. The applicant must show it has access to a recognised CCP. In Hong Kong, the recognised CCPs are OTC Clearing Hong Kong Limited (OTC Clear) and Hong Kong Securities Clearing Company Limited (HKSCC). For cross-border clearing, the SFC may recognise CCPs in other jurisdictions under section 104 of Cap. 571. The applicant must provide a clearing agreement with the CCP and evidence of operational readiness, including system testing results.

Step 4: Submit and await SFC decision. The SFC aims to process Type 11 applications within 12 weeks from the date of a complete submission. The SFC’s Licensing Handbook states that incomplete applications will be returned. The SFC charges an application fee of HK$4,740 (as of 2024) for each regulated activity.

Ongoing Compliance Obligations

Once licensed, a Type 11 licensee must comply with a comprehensive regulatory framework. The SFC and HKMA share oversight responsibility for OTC derivative clearing.

Capital and margin requirements. The SFC’s Financial Resources Rules require the licensee to maintain liquid capital at all times. In addition, the HKMA’s Banking (Capital) Rules (Cap. 155L) apply to authorised institutions that hold a Type 11 license. The Basel III framework, implemented in Hong Kong through the HKMA’s Supervisory Policy Manual, requires clearing members to hold capital against their exposure to CCPs. The HKMA’s 2024 Consultation Paper on Margin Requirements for Non-Centrally Cleared Derivatives proposed extending margin requirements to new product classes from September 2025. Licensees must monitor these changes.

Reporting and record-keeping. Section 405 of Cap. 571 requires a licensed corporation to keep proper books and records for at least seven years. The SFC’s Code of Conduct requires the licensee to report all OTC derivative transactions to a trade repository within one business day. The HKMA operates the Hong Kong Trade Repository (HKTR) for this purpose. The SFC’s Guidelines on Reporting of OTC Derivative Transactions (March 2023) specify the data fields and reporting format.

Client money and asset segregation. If the Type 11 licensee holds client money or assets for clearing purposes, it must comply with the Securities and Futures (Client Money) Rules (Cap. 571H) and the Securities and Futures (Client Securities) Rules (Cap. 571I). These rules require strict segregation of client assets from the licensee’s own assets. The SFC’s Thematic Review on Client Asset Segregation (October 2022) found that 12% of inspected firms had deficiencies in their segregation practices. Licensees must conduct annual internal audits and submit a compliance report to the SFC.

Risk management and governance. The SFC Code requires the licensee to establish a risk management committee with clear terms of reference. The committee must review the licensee’s exposure to CCPs, counterparty credit risk, and operational risk. The SFC’s Guidelines on the Management of Operational Risk (January 2023) require the licensee to have a business continuity plan and to test it annually. The HKMA’s Supervisory Policy Manual module IC-1 (Risk Management of OTC Derivative Activities) provides additional guidance for authorised institutions.

Recent Developments and Market Impact

The regulatory landscape for OTC derivative clearing in Hong Kong is evolving rapidly. Two developments in 2024-2025 are particularly relevant.

Expansion of mandatory clearing. The HKMA and SFC joint consultation conclusion of 2 January 2025 confirmed that mandatory clearing will apply to:

• Foreign exchange (FX) forwards and swaps with a maturity of up to one year, effective 1 July 2025.
• Credit default swaps (CDS) referencing Asian entities, effective 1 January 2026.
• Interest rate swaps (IRS) in Hong Kong dollar and offshore renminbi, effective 1 July 2025.

The HKMA estimated in the consultation paper that this expansion would affect approximately 200 firms, of which around 60 would need to become clearing members or use a clearing member. This represents a significant increase from the 14 existing Type 11 licensees.

Cross-border clearing and recognition of foreign CCPs. The SFC and HKMA have been working with mainland Chinese regulators to facilitate cross-border clearing. The Memorandum of Understanding on Cross-Border Clearing of OTC Derivatives between the SFC and the China Securities Regulatory Commission (CSRC), signed in November 2023, allows Hong Kong clearing members to clear trades for mainland clients through recognised CCPs. The SFC’s Guidelines on the Recognition of Overseas CCPs (January 2024) set out the criteria for recognition, including compliance with the Principles for Financial Market Infrastructures (PFMI) issued by the Committee on Payments and Market Infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO).

Implications for market participants. Firms that currently clear OTC derivatives through a non-licensed entity must reassess their structure. The SFC has indicated that it will take enforcement action against unlicensed clearing activities. In its 2023-24 Annual Report, the SFC noted that it had conducted 15 inspections of firms suspected of providing unlicensed clearing services. Two firms were reprimanded and fined a total of HK$8.5 million.

Actionable Takeaways

1. Firms that book OTC derivative trades in Hong Kong must assess by 30 June 2025 whether the new mandatory clearing obligations apply to their product classes and, if so, whether they need a Type 11 license.
2. The Type 11 application process requires a clear business plan, a risk management policy, and evidence of clearing infrastructure, with the SFC targeting a 12-week processing time for complete submissions.
3. Licensed Type 11 firms must maintain liquid capital of at least HK$5 million, but the SFC expects significantly higher levels in practice, with the median being HK$50 million as of 2024.
4. Ongoing compliance includes reporting all OTC derivative transactions to the HKTR within one business day and maintaining strict segregation of client assets under Cap. 571H and Cap. 571I.
5. Cross-border clearing opportunities exist under the SFC-CSRC MOU, but firms must ensure their overseas CCP counterpart is recognised by the SFC under the January 2024 guidelines.

This does not constitute legal advice. Consult a solicitor for your specific case.